Midwest Trust’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$204K Buy
+5,368
New +$247K ﹤0.01% 618
2026
Q2
– Sell
-6,853
Closed -$252K – 624
2026
Q1
$252K Sell
6,853
-352
-5% -$16.7K ﹤0.01% 542
2025
Q4
$367K Sell
7,205
-1,051
-13% -$53.7K ﹤0.01% 471
2025
Q3
$458K Sell
8,256
-424
-5% -$24.8K 0.01% 436
2025
Q2
$599K Buy
+8,680
New +$590K 0.01% 398

Other funds holding NVO

Midwest Trust's NVO Position: Q3 2026 in Review

Midwest Trust opened a new position in Novo Nordisk (NVO) in Q3 2026: 5,368 shares worth $204K. The stake represents ﹤0.01% of the portfolio and ranks #618 among its holdings. This is a return to the name: Midwest Trust previously reported a position in NVO as recently as Q1 2026.

Midwest Trust first reported a position in NVO in Q2 2025 and has held it in 5 quarters since. The position peaked at $599K in Q2 2025. 696 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Midwest Trust held 5,368 shares of Novo Nordisk worth $204K as of Q3 2026.
  • Novo Nordisk was a new Midwest Trust position in Q3 2026.
  • Novo Nordisk made up ﹤0.01% of Midwest Trust's portfolio in Q3 2026, its #618 holding.
  • Midwest Trust first reported a position in Novo Nordisk in Q2 2025 and has held it in 5 quarters since.
  • Midwest Trust's Novo Nordisk position peaked at $599K in Q2 2025.
  • 696 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Midwest Trust's 13F filing for Q3 2026, filed 22 Oct 2026.